Through its Leap brand, the Danish startup cuts food waste by turning apples junked in cider factories into affordable vegan leather for the $100bn leather market
Amid the crackdown on China’s tech giants, some investors are sussing out less risky sectors, while heavyweights like BlackRock and Fidelity stay in for the long haul
Get plugged into the innovative tech startups driving the world’s fastest-growing ecosystems
Meatable’s proprietary OPTi-OX technology is a pioneer in enabling scalable cell-based production of entire meat joints, 100% animal-free, starting with pork and beef.
Vegan leather made from apple waste is recyclable and biodegradable; produces 85% less CO2, uses 99% less water than leather; for sustainable textiles and fashion.
TreeFrog Therapeutics’ C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment that mimics the way cells grow in the human body.
Mark Kotter is the Austrian co-founder at Dutch cell-based meat startup Meatable, the first to use pluripotent stem cells and claim a highly scalable culture technology, which was developed by Kotter prior to founding the startup in 2018. He is also founder at his biotech startup, bit.bio, which is based in Cambridge, UK, since 2016, where he applies his cellular technological innovation to human stem cell research and has raised investments totaling $42m. His main full-time position is at the University of Cambridge, where he has worked since 2009. He has spent more than five years as a clinician-scientist in stem cell research and was previously a lecturer in neurosurgery. Kotter also lectures at Paris Descartes University and is a team leader at the UK’s National Institute for Health Research’s Brain Injury MedTech Co-operative. He also founded Myelopathy.org to raise awareness of cervical myelopathy. His past positions were as a research group leader at the Max Planck Institute for Experimental Medicine for one year, and for two years spent at the Medical University of Vienna. Kotter holds two doctorates; one in philosophy from the University of Cambridge and the other in medicine from the University of Graz in Austria. Kotter also holds a master’s in philosophy from the University of Cambridge.
Albert Wenger is a managing partner at New York-based Union Square Ventures. He is also an angel investor with disclosed investments in 25 startups, many in the area of sustainability. His most recent investments have been in the April 2021 $6.2m seed round of Finnish carbon sequestration startup Carbon Culture and in the $9.5m Series A round of French web browser innovation company Beam.
Meatable’s proprietary OPTi-OX technology is a pioneer in enabling scalable cell-based production of entire meat joints, 100% animal-free, starting with pork and beef.
Vegan leather made from apple waste is recyclable and biodegradable; produces 85% less CO2, uses 99% less water than leather; for sustainable textiles and fashion.
TreeFrog Therapeutics’ C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment that mimics the way cells grow in the human body.
Mark Kotter is the Austrian co-founder at Dutch cell-based meat startup Meatable, the first to use pluripotent stem cells and claim a highly scalable culture technology, which was developed by Kotter prior to founding the startup in 2018. He is also founder at his biotech startup, bit.bio, which is based in Cambridge, UK, since 2016, where he applies his cellular technological innovation to human stem cell research and has raised investments totaling $42m. His main full-time position is at the University of Cambridge, where he has worked since 2009. He has spent more than five years as a clinician-scientist in stem cell research and was previously a lecturer in neurosurgery. Kotter also lectures at Paris Descartes University and is a team leader at the UK’s National Institute for Health Research’s Brain Injury MedTech Co-operative. He also founded Myelopathy.org to raise awareness of cervical myelopathy. His past positions were as a research group leader at the Max Planck Institute for Experimental Medicine for one year, and for two years spent at the Medical University of Vienna. Kotter holds two doctorates; one in philosophy from the University of Cambridge and the other in medicine from the University of Graz in Austria. Kotter also holds a master’s in philosophy from the University of Cambridge.
Albert Wenger is a managing partner at New York-based Union Square Ventures. He is also an angel investor with disclosed investments in 25 startups, many in the area of sustainability. His most recent investments have been in the April 2021 $6.2m seed round of Finnish carbon sequestration startup Carbon Culture and in the $9.5m Series A round of French web browser innovation company Beam.
Meatable’s proprietary OPTi-OX technology is a pioneer in enabling scalable cell-based production of entire meat joints, 100% animal-free, starting with pork and beef.
Vegan leather made from apple waste is recyclable and biodegradable; produces 85% less CO2, uses 99% less water than leather; for sustainable textiles and fashion.
TreeFrog Therapeutics’ C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment that mimics the way cells grow in the human body.
Mark Kotter is the Austrian co-founder at Dutch cell-based meat startup Meatable, the first to use pluripotent stem cells and claim a highly scalable culture technology, which was developed by Kotter prior to founding the startup in 2018. He is also founder at his biotech startup, bit.bio, which is based in Cambridge, UK, since 2016, where he applies his cellular technological innovation to human stem cell research and has raised investments totaling $42m. His main full-time position is at the University of Cambridge, where he has worked since 2009. He has spent more than five years as a clinician-scientist in stem cell research and was previously a lecturer in neurosurgery. Kotter also lectures at Paris Descartes University and is a team leader at the UK’s National Institute for Health Research’s Brain Injury MedTech Co-operative. He also founded Myelopathy.org to raise awareness of cervical myelopathy. His past positions were as a research group leader at the Max Planck Institute for Experimental Medicine for one year, and for two years spent at the Medical University of Vienna. Kotter holds two doctorates; one in philosophy from the University of Cambridge and the other in medicine from the University of Graz in Austria. Kotter also holds a master’s in philosophy from the University of Cambridge.
Albert Wenger is a managing partner at New York-based Union Square Ventures. He is also an angel investor with disclosed investments in 25 startups, many in the area of sustainability. His most recent investments have been in the April 2021 $6.2m seed round of Finnish carbon sequestration startup Carbon Culture and in the $9.5m Series A round of French web browser innovation company Beam.
Organised by
In partnership with
In collaboration with
Organised by
Supported by
In partnership with
Brought to you by
About us
Sign up for our newsletter to get the latest news and analysis about innovative tech startups
Sign upYour payment was not successful.
Please make sure you have entered your payment details correctly. Or try again in a few moments.
The discount code you entered is invalid
Please make sure you have entered your discount code correctly. Or try again in a few moments.
Download successful.
Your sample has been sent. Please check your email.
